Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04130269

Anxiety, Stress and Pain & Myocardial Infarction

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing Posttraumatic Stress Disorder (PTSD) after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress, and PTSD after an acute myocardial infarction.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Graz

Graz, Styria, 8036, Austria

Location status: Recruiting

Location contact

Andreas Baranyi, Prof. MD

CONTACT

[email protected]

+4331638586241

About this study

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing PTSD after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress and PTSD after an acute myocardial infarction.

Patients will be examined during three times - in the acute myocardial infarction period (Day 1-3), before dismissal (Day 5-14) and after 6 months for a follow-up. During all times they will be given questionnaires asking about their levels of stress, anxiety and general well-being as well as tests checking their cognitive abilities (thus to find out if they decrease over time). Moreover, blood samples checking cortisol levels as well as metanephrine levels will be taken in order to objectify the levels of stress that are stated by the patients. Furthermore, clinical evaluations, laboratory runs (troponin), ECGs and echocardiographies will be done at all three points in time.

The goal is to detect the biopsychosocial relations and to develop better prevention.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • willingness to participate in the study
  • men and women 19-90
  • after myocardial infarctions
  • no psychiatric disease before myocardial infarction
  • no other severe disease influencing the immune system

Exclusion criteria

  • non fulfilment of inclusion criteria
  • non-compliant patients (dementia, delirium)
  • steroid-therapy

Treatment and study plan

No intervention

Other

Questionnaires, lab-run

Primary outcomes

  1. PTSD

    Time frame: 6 months

    Number of patients who develop PTSD

Study contacts

Contact information is provided by the study sponsor or research team.

Andreas Baranyi, MD

CONTACT

[email protected]

004331638513612

Hans-Bernd Rothenhäusler, MD

CONTACT

004331638513612

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Registry information

Official study title

The Impact of Anxiety, Stress and Pain in the Early Phase of Myocardial Infarction on the Development of Anxiety Symptoms and Posttraumatic Stress Disorder in the Long Term Outcome

Important dates

Study start
2020
Primary completion
2027
Study completion
2027
First posted
Oct 17, 2019
Registry last updated
Sep 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.